Galectin-1 as a potential cancer target
2005
Galectin-1 as a potential cancer target
publication
Evidence: moderate
Author Information
Author(s): G A Rabinovich
Primary Institution: University of Buenos Aires, Argentina
Hypothesis
Tumour cells may impair T-cell effector functions through secretion of galectin-1.
Conclusion
Galectin-1 contributes to tumour growth and metastasis, suggesting it could be a target for anticancer therapies.
Supporting Evidence
- Galectin-1 is involved in tumour transformation and immune evasion.
- Expression of galectin-1 correlates with the aggressiveness of various tumours.
- Galectin-1 can both promote and inhibit tumour growth depending on its concentration and context.
Takeaway
Galectin-1 is a protein that helps cancer cells grow and spread, and scientists think it could be a good target for new cancer treatments.
Methodology
The review summarizes recent advances about the role of galectin-1 in tumour growth and metastasis.
Limitations
The exact mechanisms of galectin-1's effects on tumours and immune responses are still not fully understood.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website